secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2024-05-03T23:59:59+00:00
Accession:  0001493152-24-017641
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biofrontera achieves milestones on Series B-3 warrants, unlocking $8M gross proceeds
--------------------------------------------------------------------------------

- Board certified >5% YoY revenue growth (Jan-Apr 2024 vs 2023, ex-related parties) and >95% CRM adoption.
- Warrant exercise triggers $8M gross proceeds to Biofrontera.
- Shareholders approved authorized share increase from 15M to 35M at April 24 special meeting.
- Warrants expiration now 5 days after S-1 effectiveness (filed May 2) or Feb 22, 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000149315224017641/0001493152-24-017641-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000149315224017641/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-017641

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer